Passage Bio (PASG) has shared an announcement.
Kathleen Borthwick has been appointed as the Chief Financial Officer of a company, effective March 1, 2024. Her extensive experience includes various leadership roles at Johnson & Johnson and a strong academic background from Wharton and Tuck Business School. Borthwick’s compensation package includes a substantial base salary, eligibility for a significant bonus, stock options, and severance benefits including full vesting of equity awards under certain conditions. She is also covered by a standard indemnification agreement with the company, ensuring her financial and legal protection.
For detailed information about PASG stock, go to TipRanks’ Stock Analysis page.
